Agenus Inc. (AGEN) — Stock Score Summary

Agenus Inc. (AGEN) has a MoatMap StockRank of 38/100 based on Quality (40/100), Value (60/100), and Momentum (25/100) factor scores. The current signal is HOLD. Agenus is a clinical-stage biotechnology company with high cash burn and no structural profitability. It violates the Terry Smith lens of avoiding speculative, non-earning businesses and does not align with our high-conviction macro themes.

Agenus Inc. is a clinical-stage immuno-oncology company focused on discovering and developing novel antibodies and cell therapies to treat cancer, including checkpoint modulators and cancer vaccines. The company's competitive moat is built on its proprietary technology platforms and extensive intellectual property, supported by strategic partnerships with major pharmaceutical firms, positioning it in the cutting-edge field of cancer immunotherapy.

Key Financial Metrics

Price$3.11
Market Cap$142M
P/E (TTM)1.66
P/E (Forward)-1.48
Price/Book-0.59
Gross Margin96.9%
Operating Margin44.6%
Revenue Growth40.2%
Free Cash Flow$-51M

Agenus Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Agenus Inc.’s (AGEN) StockRank?
MoatMap’s StockRank for Agenus Inc. (AGEN) is 38/100, with a Hold signal. It is a composite of Quality (40), Value (60), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Agenus Inc. have an economic moat?
Agenus Inc. (AGEN) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Agenus Inc. a buy, hold, or sell?
MoatMap’s current signal for Agenus Inc. (AGEN) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Agenus Inc. in?
Agenus Inc. (AGEN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAGEN deep dive reportAI ChampionsHow we score stocksSense-check another stock